38th EFI Conference Prague May 14 – 17, 2025 Immunogenetics Science and clinical applications

Breaking News:
Kathmandu Nepal
Dienstag, Apr. 29, 2025
The use of IT has proven to be a great advantage in the processing of transplant applications and improves the chances of waiting patients. A crucial element in the transplantation process is the compatibility between donor and recipient. HLA, human leukocyte antigens, play a key role in organ transplants and are crucial for compatibility.
Clinisys™ is presenting its unique product Clinisys™ GLIMS HLA Transplant Module* for immunogenetics and HLA at the EFI conference. It can be used to support the data and process flow for next-generation analyses that integrate complex and high-resolution results. Clinisys™ GLIMS HLA Transplant Module is connected to national and European donor management databases such as Cristal, Syrenad and Eurotransplant via interfaces.
Interested in hearing more?
Visit us at stand 17 or make an appointment with our experts today:
*Clinisys™ GLIMS HLA Transplant Module is integrated in the Clinisys laboratory information management system GLIMS.
Clinisys is a global provider of diagnostic informatics solutions that are redefining the modern healthcare, life sciences and public health laboratory. Every day, the Clinisys platform and our cloud-based solutions generate millions of laboratory results and data in over 3,000 laboratories in 34 countries. Clinisys is headquartered in Walluf (Germany), Ghent (Belgium), Woking (UK) and Tucson / Arizona (USA) and is dedicated to improving the effectiveness of workflows in all laboratory and testing environments and improving the health and safety of society.
Clinisys Deutschland GmbH
Am Klingenweg 6
65343 Walluf
Telefon: +49 (6123) 7016-121
Telefax: +49 (6123) 7016-499
https://www.clinisys.com/